← SynDRA
Bms-1
SynDRA canonical compound SYN1597257 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CD274 |
|---|
| Mechanism of action | programmed death ligand inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:1080051
- Pd-1/pd-l1 inhibitor 1
- PD1-PDL1 inhibitor 1
- MFCD28978741
- PD1-PDL1 inhibitor 1 (PD1-PDL1-IN1)
- PD1-PDL-inhibitor-1
- PD-1/PL-L1 Inhibitor 1
- BMS001
- orb1303951
- SCHEMBL16555159
- SCHEMBL29385036
- C29H33NO5
- EX-A947
- GLXC-09375
- BMS-1186
- BDBM50091334
- NSC823640
- s7911
- AKOS026674102
- BMS-1 (PD1/PDL1 inhibitor 1)?
- CCG-269498
- CS-5545
- NSC-823640
- NCGC00507856-02
- AC-32626
- AS-74875
- BP158531
- HY-19991
- Pd-1/Pd-L1 Inhibitor Impurity 8 (Bms 1)
- T3655
- F865760
- PD-1/PD-L1 inhibitor 1;PD1-PDL1 inhibitor 1
- BRD-K04032780-001-01-8
- BDBM365763
- DS-015881
- US9872852, Example 15
- SCHEMBL16555078
- SCHEMBL31424998
Look up Bms-1 in the interactive SynDRA portal →